Literature DB >> 8312686

Reversible hyperkinesia in a patient with autoimmune polyglandular syndrome type I.

T Baumert1, G Kleber, J Schwarz, A Stäbler, R Lamerz, K Mann.   

Abstract

Autoimmune polyglandular syndrome is characterized by a failure of multiple endocrine organs and the presence of circulating organ-specific autoantibodies targeted against the failing organs. Here we describe a patient with autoimmune polyglandular syndrome type I with the endocrine manifestations of hypoparathyroidism, adrenocortical insufficiency, and insulin-dependent diabetes mellitus. Long-standing hypoparathyroidism led to extensive calcification of the basal ganglia which resulted in the clinical presentation of an extrapyramidal movement disorder (choreoathetotic and hemiballistic hyperkinesia of the left extremities). Interestingly, parallel to rehydration and the initiation of cortisol replacement therapy a complete reversion of the hyperkinetic signs was achieved. This case shows a rare multiendocrine organ failure with complex metabolic interactions resulting in marked neurological signs. Furthermore, this case demonstrates for the first time that a hyperkinetic syndrome--most likely due to hypoparathyroidism-induced basal ganglia calcification--can be reversed solely by adequate treatment of the concomitant endocrine failures.

Entities:  

Mesh:

Year:  1993        PMID: 8312686     DOI: 10.1007/bf00185605

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  11 in total

Review 1.  T-lymphocytes and the pathogenesis of type 1 (insulin-dependent) diabetes mellitus.

Authors:  B O Roep; R R De Vries
Journal:  Eur J Clin Invest       Date:  1992-11       Impact factor: 4.686

2.  High field MR imaging of the brain in pseudohypoparathyroidism.

Authors:  Y Araki; T Furukawa; K Tsuda; T Yamamoto; I Tsukaguchi
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

3.  Human gamma delta T-cell receptor-positive cell-mediated inhibition of erythropoiesis in vitro in a patient with type I autoimmune polyglandular syndrome and pure red blood cell aplasia.

Authors:  T Hara; Y Mizuno; M Nagata; Y Okabe; S Taniguchi; M Harada; Y Niho; K Oshimi; S Ohga; Y Yoshikai
Journal:  Blood       Date:  1990-02-15       Impact factor: 22.113

Review 4.  Autoimmune polyglandular syndromes.

Authors:  M Neufeld; N Maclaren; R Blizzard
Journal:  Pediatr Ann       Date:  1980-04       Impact factor: 1.132

5.  Autoimmune polyendocrinopathy--candidosis--ectodermal dystrophy (APECED): autosomal recessive inheritance.

Authors:  P Ahonen
Journal:  Clin Genet       Date:  1985-06       Impact factor: 4.438

6.  Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

Authors:  P Ahonen; S Myllärniemi; I Sipilä; J Perheentupa
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

Review 7.  Autoimmune diseases of the adrenal glands, parathyroid glands, gonads, and hypothalamic-pituitary axis.

Authors:  A Muir; N K Maclaren
Journal:  Endocrinol Metab Clin North Am       Date:  1991-09       Impact factor: 4.741

8.  Idiopathic hypoparathyroidism with extensive brain calcification and persistent neurologic dysfunction.

Authors:  J H Friedman; I Chiucchini; J R Tucci
Journal:  Neurology       Date:  1987-02       Impact factor: 9.910

9.  Autosomal dominant idiopathic hypoparathyroidism and nervous system dysfunction: report of three cases and review of the literature.

Authors:  M Smits; F Gabreëls; P Froeling; H Thijssen; E Colon; B ter Haar; C Ruland; R Lam
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

Review 10.  Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes.

Authors:  M Neufeld; N K Maclaren; R M Blizzard
Journal:  Medicine (Baltimore)       Date:  1981-09       Impact factor: 1.889

View more
  2 in total

Review 1.  Hypoparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

2.  Recessive developmental delay, small stature, microcephaly and brain calcifications with locus on chromosome 2.

Authors:  Anna Rajab; Kimberly A Aldinger; Hisham Ali El-Shirbini; William B Dobyns; M Elizabeth Ross
Journal:  Am J Med Genet A       Date:  2009-02       Impact factor: 2.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.